Filing metadata

Accession number
0001328143-21-000067
Form type
Form 4
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Jun 23, 2021
Reporting period
Jun 21, 2021
Description
Insider transaction

Explore SEC Filings Hub